Delivering Targeted therapy across the surface of the beating heart

About CardioScout

CardioScout is a single use minimally invasive device platform for the fully articulated delivery of catheters under direct vision into the epicardium to the therapy target or targets on the surface of the beating heart. This results in a safer, faster, and more precise treatment with better clinical outcomes and lower hospital costs.

CardioScout Team

James Fonger MD – Founder and CEO

  • Minimally invasive cardiac surgeon trained at Johns Hopkins Hospital
  • Surgical device developer with two prior exits to strategic medical device companies

Larry Blankenship – COO

  • Medical device entrepreneur with endoscopic and ablation catheter experience
  • Will oversee the company design and manufacturing operations in Colorado

Mickael Flaa - CFO

  • Prior KPMG partner with extensive domestic and international executive experience
  • Public and private startups, turnarounds, exits and IPO. President, CFO, and Board Member of injectable biologic company

Enabling epicardial therapy across the surface of the heart

“Performs like a lunar rover on the surface of the beating heart”

For more information contact:

Our News

Boulder iQ Selects CardioScout for Medical Device Accelerator Program

By Medical Alley – March 9, 2021

a. $8.6 million Advanced Industries Awards Accelerate 36 Colorado Start-ups - CardioScout Innovations Inc., Boulder — $250,000.

By Colorado Office of Economic development & International Trade – May 20, 2021